Design and synthesis of novel delta opioid receptor agonists and their pharmacologies

Bioorg Med Chem Lett. 2009 May 15;19(10):2792-5. doi: 10.1016/j.bmcl.2009.03.099. Epub 2009 Mar 26.

Abstract

We re-examined the accessory site of the 4,5-epoxymorphinan skeleton by camdas conformational analysis in an effort to deign novel delta opioid receptor antagonists. We synthesized three novel compounds (SN-11, 23 and 28) with a 10-methylene bridge and without a 4,5-epoxy ring. Among them, compounds SN-23 (17-isobutyl derivative) and SN-28 (17-methyl derivative) showed very strong agonist activity (over 10 times more than TAN-67). SN-28 also showed high delta selectivity. The delta agonist activity of SN-23 was weaker than that of SN-28, but in terms of the delta selectivity, SN-23 was higher than that of SN-28. These unexpected results indicated that the 4,5-epoxy ring, but not the 10-methylene bridge, was an accessory site in delta opioid receptor agonists.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Drug Design
  • Morphinans / chemical synthesis*
  • Morphinans / chemistry*
  • Morphinans / pharmacology
  • Naltrexone / analogs & derivatives*
  • Naltrexone / chemical synthesis
  • Naltrexone / chemistry
  • Receptors, Opioid, delta / agonists*
  • Receptors, Opioid, delta / metabolism

Substances

  • 4,5-epoxymorphinan
  • Morphinans
  • Receptors, Opioid, delta
  • SN-23 compound
  • SN-28 compound
  • Naltrexone
  • naltrindole